Targeting TREM2 with Small Molecule Agonists to Modulate Neuroinflammation in Alzheimer’s Disease
Time: 10:45 am
day: Day Two
Details:
• Highlighting TREM2 agonist ability to modulate inflammation in neurological indications
• Investigating TREM2 biology to identify the best stage of intervention
• Outlining model development and biomarker strategy to optimize translation into the clinic
